Drug Shortage Report for HALOPERIDOL INJ 5MG/ML USP
| Report ID | 177931 |
| Drug Identification Number | 00808652 |
| Brand name | HALOPERIDOL INJ 5MG/ML USP |
| Common or Proper name | HALOPERIDOL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 5MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1ML |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2022-12-12 |
| Estimated end date | 2023-03-03 |
| Actual end date | 2023-01-31 |
| Shortage status | Resolved |
| Updated date | 2023-02-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-02-01 | English | Compare |
| v7 | 2023-01-31 | French | Compare |
| v6 | 2023-01-31 | English | Compare |
| v5 | 2023-01-27 | French | Compare |
| v4 | 2023-01-27 | English | Compare |
| v3 | 2022-12-13 | English | Compare |
| v2 | 2022-12-12 | French | Compare |
| v1 | 2022-12-12 | English | Compare |
Showing 1 to 8 of 8